Approval · Notice of Compliance 8092 · 2006
KOGENATE FS: Notice of Compliance 8092
Issued June 30, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8092
- Date
- June 30, 2006
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New production area
- Therapeutic class
- Coagulation factor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KOGENATE FS | Not yet assigned | — |
Medicinal ingredients
- ANTIHEMOPHILIC FACTOR (RECOMBINANT) 500 UNIT per VIAL
- ANTIHEMOPHILIC FACTOR (RECOMBINANT) 250 UNIT per VIAL
- ANTIHEMOPHILIC FACTOR (RECOMBINANT) 1,000 UNIT per VIAL
- ANTIHEMOPHILIC FACTOR (RECOMBINANT) 250 UNIT per 2.5ML
- ANTIHEMOPHILIC FACTOR (RECOMBINANT) 500 UNIT per 2.5ML
- ANTIHEMOPHILIC FACTOR (RECOMBINANT) 1,000 UNIT per 2.5ML